AF
TECX

Amalgamated Financial’s Tectonic Therapeutic TECX Stock Holding History

Amalgamated Financial’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$6K Buy
+380
New +$7.85K ﹤0.01% 2957

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's TECX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Tectonic Therapeutic (TECX) in Q1 2022: 380 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2957 among its holdings.

80 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Amalgamated Financial held 380 shares of Tectonic Therapeutic worth $6K as of Q1 2022.
  • Tectonic Therapeutic was a new Amalgamated Financial position in Q1 2022.
  • Tectonic Therapeutic made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2957 holding.
  • 80 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.